Skip to main content
Log in

Characteristics of binding of [3H]NE-100, a novel sigma-receptor ligand, to guinea-pig brain membranes

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

We examined the characteristics of binding of radiolabeled N,N-dipropyl-2-[4-methoxy-3-(2-phenylethoxy)phenyl]-ethylamine monohydrochloride ([3H] NE-100), a highly potent and selective sigma-receptor ligand, to guinea-pig brain membranes. [3H]NE-100 showed saturable and reversible binding to sigma binding sites. A dissociation constant (Kd) and maximal numbers of binding sites (B max) obtained from Scatchard plot analysis were 1.2 ± 0.1 nM and 1049.3 ± 115.1 fmol/mg protein (n = 3), respectively. NE-100 was the most potent inhibitor of [3H]NE-100 binding among several structurally dissimilar sigma-receptor ligands, including haloperidol and ( + )-pentazocine. ( + )-Benzomorphanes had more than a 10-fold potent inhibitory activity over (−)-benzomorphanes, with regard to [3H]NE-100 binding. The binding of [3H]NE-100 was not influenced by histaminergic, dopaminergic, adrenergic, serotonergic cholinergic or glutaminergic agents at 10−7 M. GTP-γ-S and phenytoin also did not affect the binding of [3H]NE-100. A higher [3H]NE-100 binding was observed in the cerbellum and medulla oblongata. Except for the nuclear fraction, the highest level of [3H]NE-100 binding to subcellular fractions was observed in microsomal fractions. These results suggest that NE-100 selectively binds, with a high affinity, to sigma-1 binding sites in guinea-pig brain membranes, as an “antagonist”.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Bylund DB, Snyder SH (1976) Beta-adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol 12:568–580

    Google Scholar 

  • Chaki S, Tanaka M, Muramatsu M, Otomo S (1994) NE-100, a novel potent σ ligand, preferentially binds to σ1 binding sites in guinea pig brain. Eur J Pharmacol 251:R1-R2

    Google Scholar 

  • Cheng YC, Prusoff WH (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22:3099–3108

    Article  CAS  PubMed  Google Scholar 

  • Craviso GL, Musacchio JM (1983a) High-affinity dextromethorphan binding sites in guinea pig brain. I. Initial characterization. Mol Pharmacol 23:619–628

    Google Scholar 

  • Craviso GL, Musacchio JM (1983b) High-affinity dextromethorphan binding sites in guinea pig brain. II. Competition experiments. Mol Pharmacol 23:629–640

    Google Scholar 

  • Culp SG, Rominger D, Tam WS, De Souza E (1992) [3H]DuP734 (1-cyclopropylmethyl]-4-(2′-(4″-fluorophenyl)-2′-oxoethyl)-piperidine HBr): a receptor binding profile of a high-affinity novel sigma receptor ligand in guinea pig brain. J Pharmacol Exp Ther 263:1175–1187

    Google Scholar 

  • De Costa BR, Bowen WD, Hellewell SB, Walker JM, Thurkauf A, Jacobson AE, Rice KC (1989) Synthesis and evaluation of optically pure [3H]-(+)-pentazocine, a highly potent and selective radioligand for σ receptors. FEBS Lett 251:53–58

    Google Scholar 

  • Gray NM, Contreras PC, Allen SE, Taylor DP (1990) H1 antihistamines interact with central sigma receptors. Life Sci 47:175–180

    Google Scholar 

  • Gundlach AL, Largent BL, Snyder SH (1985) Phencyclidine and σ opiate receptors in brain: biochemical and autoradiographic differentiation. Eur J Pharmacol 113:465–466

    Google Scholar 

  • Gundlach AL, Largent BL, Snyder SH (1986) Autoradiographic localization of σ-receptor binding sites in guinea pig and rat central nervous system with (+)-3H-3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. J Neurosci 6:1757–1770

    Google Scholar 

  • Itzhak Y (1988) Pharmacological specificity of some psychotomimetic and antipsychotic agents for the sigma and PCP binding sites. Life Sci 42:745–752

    Google Scholar 

  • Itzhak Y (1989) Multiple affinity binding sites of the σ receptor: effect of GTP-binding protein-modifying agents. Mol Pharmacol 36:512–517

    Google Scholar 

  • Karbon EW, Naper K, Pontecorvo MJ (1991) [3H]DTG and [3H]( + )-3-PPP label pharmacologically distinct σ binding sites in guinea pig brain membranes. Eur J Pharmacol 193:21–27

    Google Scholar 

  • Katz JL, Spealman RD, Clark RD (1985) Stereoselective behavioral effects of N-allylnormetazocine in pigeons and squirrel monkeys. J Pharmacol Exp Ther 232:452–461

    Google Scholar 

  • Knight AR, Nobel A, Wong EHF, Middlemiss DN (1991) The subcellular distribution and pharmacology of the sigma recognition site in guinea-pig brain and liver. Mol Neuropharmacol 1:71–75

    Google Scholar 

  • Largent BL, Gundlach Al, Snyder SH (1984) Psychotomimetic opiate receptors labeled and visualized with (+)-[3H]3-(3-hydroxyphenyl)-N-(1-propyl)piperidine. Proc Natl Acad Sci USA 81:4983–4987

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  • Manallack DT, Wong MG, Costa M, Andrews PR, Beart PM (1988) Receptor site topographies for phencyclidine-like and σ drugs: predictions from quantitative conformational, electrostatic potential, and radioreceptor analysis. Mol Pharmacol 34:863–879

    Google Scholar 

  • Martin WR, Eades CG, Thompson JA, Huppler RE, Gilbert PE (1976) The effects of morphine- and nalorphine-like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther 197:517–532

    Google Scholar 

  • McCann DJ, Rabin RA, Rens-Domiano S, Winter JC (1989) Phencyclidine/SKF-10,047 binding sites: evaluation of function. Pharmacol Biochem Behav 32:87–94

    Google Scholar 

  • McCann DJ, Su TP (1990) Haloperidol sensitive [3H](+)-SKF10,047 binding sites (σ sites) exhibit a unique distribution in rat subcellular fractions. Eur J Pharmacol 188:211–218

    Google Scholar 

  • McLean S, Weber E (1988) Autoradiographic visualization of haloperidol-sensitive sigma receptors in guinea-pig brain. Neuroscience 25:259–269

    Google Scholar 

  • Mendelsohn LG, Kalra V, Johnson BG, Kerchner GA (1985) Sigma opioid receptor; characterization and co-identity with the phencyclidine receptor. J Pharmacol Exp Ther 233:597–602

    Google Scholar 

  • Musacchio JM, Klein M, Santiago LJ (1987) Allosteric modulation of dextromethorphan binding sites. Neuropharmacology 26:997–1001

    Google Scholar 

  • Okuyama S, Imagawa Y. Ogawa S, Araki H, Ajima A, Tanaka M, Muramatsu M, Nakazato A, Yamaguchi K, Yoshida M, Otomo S (1993) NE-100, a novel sigma receptor ligand: in vivo tests. Life Sci 53:PL285-PL290

    Google Scholar 

  • Quirion R, Chicheportich R, Contreras PC, Johnson KM, Lodge D, Tam SW, Woods JH, Zukin SR (1987) Classification and nomenclature of phencyclidine and sigma receptor sites. Trends Neurosci 10:444–446

    Google Scholar 

  • Quirion R, Bowen WD, Itzhak Y, Junien JL, Musacchio JM, Rothman RB, Su TP, Tam SW, Taylor DP (1992) A proporsal for the classification of sigma binding sites. Trends Pharmacol Sci 13:85–86

    Article  CAS  PubMed  Google Scholar 

  • Ross SB (1991) Heterogeneous binding of sigma radioligands in the rat brain and liver: possible relationship to subforms of cytochrome P-450. Pharmacol Toxicol 68:293–301

    Google Scholar 

  • Su TP (1982) Evidence for sigma opioid receptor: binding of [3H]SKF-10047 to morphine-inaccessible sites in guinea-pig brain. J Pharmacol Exp Ther 223:284–290

    Google Scholar 

  • Tam SW (1983) Naloxone-inaccessible sigma receptor in rat central nervous system. Proc Natl Acad Sci USA 80:6703–6707

    Google Scholar 

  • Tam SW, Cook L (1984) σ-Opiates and certain antipsychotic drugs mutually inhibit (+)-[3H]SKF10,047 and [3H]haloperidol binding in guinea pig brain membranes. Proc Natl Acad Sci USA 81:5618–5621

    Google Scholar 

  • Tanaka M, Chaki S, Imagawa Y, Okuyama S, Muramatsu M, Otomo S (1993a) FH-510, a potent and selective ligand for rat brain a recognition sites. Eur J Pharmacol 238:89–92

    Google Scholar 

  • Tanaka M, Kaku S, Muramatsu M, Otomo S (1993b) Binding of [3H]FH-510 to σ ligand recognition sites in guinea-pig brain membranes. Eur J Pharmacol 238:93–100

    Google Scholar 

  • Vaupel DB (1983) Naltrexone fails to antagonize the a effects of PCP and SKF10,047 in the dog. Eur J Pharmacol 92:269–274

    Google Scholar 

  • Walker JM, Bowen WD, Matsumoto RR, De Costa B, Rice KC (1990) Sigma receptors: biology and function. Pharmacol Rev 42:355–402

    CAS  PubMed  Google Scholar 

  • Weber E, Sonders M, Quarum M, McLean S, Pon S, Keana JF (1986) 1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci USA 83: 8784–8788

    Google Scholar 

  • Zhou G-Z, Musacchio JM (1991) Computer-assisted modeling of multiple dextromethorphane and sigma binding sites in guinea pig brain. Eur J Pharmacol 206:261–269

    Google Scholar 

  • Zukin SR, Brady KT, Slifer BL, Balster RL (1984) Behavioral and biochemical stereoselectivity of sigma opiate/PCP receptors. Brain Res 294:174–177

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tanaka, M., Shirasaki, T., Kaku, S. et al. Characteristics of binding of [3H]NE-100, a novel sigma-receptor ligand, to guinea-pig brain membranes. Naunyn-Schmiedeberg's Arch Pharmacol 351, 244–251 (1995). https://doi.org/10.1007/BF00233243

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00233243

Key words

Navigation